SCHEMBL19909753

SCHEMBL19909753

CCOC(=O)c1sc(N2CCCCC2)nc1-c1ccc(Oc2ccccc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.62
HTT P42858 4/20 0.62
NPSR1 Q6W5P4 3/20 0.62
SMN1; SMN2 Q16637 4/20 0.55
TDP1 Q9NUW8 2/20 0.55
ALOX5 P09917 1/20 0.55
MAPT P10636 4/20 0.52
HPGD P15428 4/20 0.52
GAA P10253 2/20 0.52
KDM4E B2RXH2 2/20 0.52
L3MBTL1 Q9Y468 2/20 0.52
MAPK1 P28482 1/20 0.52
HSD17B10 Q99714 1/20 0.52
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
SCN9A Q15858 1/20 0.50
DHODH Q02127 4/20 0.49
LMNA P02545 1/20 0.49
CDC7 O00311 1/20 0.48
DBF4 Q9UBU7 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16597702 0.90 ALDH1A1 (0.50) ALDH1A1HTTNPSR1SMN1; SMN2TDP1
SCHEMBL16075307 0.85 CKS1B (0.49) ALDH1A1HTTNPSR1HPGDGAA
SCHEMBL19909712 0.84 ALDH1A1 (0.65) ALDH1A1HTTNPSR1SMN1; SMN2TDP1
SCHEMBL19909686 0.83 ALDH1A1 (0.63) ALDH1A1HTTNPSR1SMN1; SMN2TDP1
SCHEMBL4086525 0.82 DHODH (0.59) ALDH1A1HTTNPSR1SMN1; SMN2TDP1
SCHEMBL16075321 0.81 ALDH1A1 (0.43) ALDH1A1HTTNPSR1SMN1; SMN2TDP1
SCHEMBL16075310 0.81 ALDH1A1 (0.44) ALDH1A1HTTNPSR1HPGDGAA
SCHEMBL16075312 0.81 BTK (0.49) ALDH1A1HTTNPSR1GAAHSD17B10
SCHEMBL1919885 0.80 ALDH1A1 (0.61) ALDH1A1HPGDHSD17B10MEN1KMT2A
SCHEMBL16127654 0.80 BTK (0.41) ALDH1A1HTTNPSR1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970163-B1 5-THIAZOLECARBOXAMIDE DERVATIVES AND THEIR USE AS BTK INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2018-02-28 EP disclosed